Construction and transformation of stimuli-responsive vesicles from the ferrocene derivative supramolecular amphiphiles

Recent Advances in ROS-Sensitive Nano-Formulations for Atherosclerosis Applications

Over the past decade, ROS-sensitive formulations have been widely used in atherosclerosis applications such as ROS scavenging, drug delivery, gene delivery, and imaging. The intensified interest in ROS-sensitive formulations is attributed to their unique self-adaptive properties, involving the main molecular mechanisms of solubility switch and degradation under the pathological ROS differences in atherosclerosis. This review outlines the advances in the use of ROS-sensitive formulations in atherosclerosis applications during the past decade, especially highlighting the general design requirements in relation to biomedical functional performance.

Functional ferrocene polymer multilayer coatings for implantable medical devices: Biocompatible, antifouling, and ROS-sensitive controlled release of therapeutic drugs

Bacterial infections and the formation of biofilms on the surface of implantable medical devices are critical issues that cause device failure. Implantable medical devices, such as drug delivery technologies, offer promising benefits for targeted and prolonged drug release, but a number of common disadvantages arise that include inadequate release and side effects. Organic film coatings for antifouling and drug delivery are expected to overcome these challenges. Ferrocene polymer-based multifunctional multilayer films were prepared to control the reactive oxygen species (ROS)-responsive release of therapeutic agents while maintaining an antifouling effect and improving biocompatibility. Polymers based on ferrocene and polyethylene glycol were prepared by controlling the molar ratio of carboxylate and amine groups. Layer-by-layer deposition was optimized to achieve the linear growth and self-assembly of dense and stable films. Outstanding anti-biofilm activity (~91% decrease) could be achieved and the films were found to be blood compatible. Importantly, the films effectively incorporated hydrophobic drugs and exhibited dual-responsive drug release at low pH and under ROS conditions at physiological pH. Drug delivery to MCF-7 breast cancer cells was achieved using a Paclitaxel loaded film, which exhibited an anticancer efficacy of 62%. STATEMENT OF SIGNIFICANCE: Healthcare associated infection is caused by the formation of a biofilm by bacteria on the surface of a medical device. In order to solve this, extensive research has been conducted on many coating technologies. Also, a method of chemical treatment by releasing the drug when it enters the body by loading the drug into the coating film is being studied. However, there is still a lack of technology that can achieve both functions of preventing biofilm production and drug delivery. Therefore, in this study, a multilayer thin film that supports drug and inhibits biofilm formation was prepared through Layer-by-Layer coating of a polymer containing PEG to prevent adsorption. As such, it helps the design of multifunctional coatings for implantable medical devices.

Fabrication of a β-cyclodextrin-based self-assembly containing a redox-responsive ferrocene

The current research involves fabrication of a redox-responsive self-assembly system based on a ferrocene (Fc)-containing β-cyclodextrin (β-CD) derivative (βCD-EG-Fc). βCD-EG-Fc was synthesized, and its redox-sensitive self-assembly behavior was investigated using various techniques. On the basis of the intermolecular host-guest recognition between the β-CD group and the Fc moiety, βCD-EG-Fc primarily formed network-like structures and then vesicles following aging for a specified time. The formation of these structures was primarily driven by hydrogen bonding. Conversely, the oxidized molecules (βCD-EG-Fc⁺) self-assembled into cationic vesicles with the absence of host-guest complexation. Upon controlling the oxidation and reduction of Fc/Fc⁺, reversible aggregate transformation was achieved. The current study resulted in a deeper understanding of β-CD/Fc redox-responsive self-assemblies and contributed to the development of a single-component host-guest inclusion model.

Redox-responsive self-assembly of β-cyclodextrin and ferrocene double-headed amphiphilic molecules

We present a redox-responsive self-assembly based on a unimolecular platform. Three double-headed amphiphilic molecules composed of β-cyclodextrin (β-CD) and ferrocene (Fc) each with an alkyl chain as a linker (βCD-C_m-Fc, m = 2, 6, and 10) were synthesized, and their self-assembly behaviors were investigated. The molecules self-assembled into polydisperse micelles that transformed into vesicles upon oxidization of the Fc moieties to Fc⁺. 2D ¹H NMR results suggest that although the three molecules formed aggregates with similar morphologies, their molecular configurations were different because of the different lengths of the alkyl chains. When the linker was a C₂ chain, no host-guest complexes were formed, whereas host-guest recognition was detected for linker lengths of C₆ and C₁₀. For the oxidized state samples, there were no host-guest interactions for linker lengths of C₂ and C₆, whereas the alkyl chain was locked in the cavity of β-CD by host-guest inclusion for the molecule with a C₁₀ linker. Moreover, reversible redox-responsive self-assemblies based on the three β-CD derivatives with a terminal Fc were successfully achieved. Our results enrich the field of β-CD/Fc reversible self-assembly systems, and provide a possible unimolecular host-guest complexation model in host-guest chemistry.

Reactive-Oxygen-Species-Responsive Drug Delivery Systems: Promises and Challenges

Given the increasing evidence indicates that many pathological conditions are associated with elevated reactive oxygen species (ROS) levels, there have been growing research efforts focused on the development of ROS-responsive carrier systems because of their promising potential to realize more specific diagnosis and effective therapy. By judicious utilization of ROS-responsive functional moieties, a wide range of carrier systems has been designed for ROS-mediated drug delivery. In this review article, insights into design principle and recent advances on the development of ROS-responsive carrier systems for drug delivery applications are provided alongside discussion of their in vitro and in vivo evaluation. In particular, the discussions in this article will mainly focus on polymeric nanoparticles, hydrogels, inorganic nanoparticles, and activatable prodrugs that have been integrated with diverse ROS-responsive moieties for spatiotemporally controlled release of drugs for effective therapy.